Proprietary Hot Melt Extrusion: Advanced HME Services Unleashed

Proprietary hot melt extrusion changes how drug formulations perform. This advanced technique blends drug and polymer under heat and pressure. With robust HME services, you improve solubility, bioavailability, and stability. Moreover, you skip complex granulation and coating steps. AbbVie Contract Manufacturing offers HME services from trials to commercial runs. Additionally, their teams optimize each process step. Consequently, you get uniform dispersions and reliable dosage forms. This article explains proprietary hot melt extrusion, HME services, and how AbbVie applies them. You will learn steps, benefits, and how to partner with a trusted manufacturer.

What Is Proprietary Hot Melt Extrusion?

Hot melt extrusion uses temperature and mechanical force to fuse drug and polymer. Proprietary hot melt extrusion uses specialized equipment and unique process profiles. It creates molecular dispersions that boost drug dissolution. First, you feed a blend of API and excipient into a heated barrel. Next, twin screws mix material under controlled shear. Then, extruded strands cool and solidify. Finally, you mill strands into uniform granules. These granules become tablets or pellets. Proprietary systems let you fine-tune temperature zones and screw design. As a result, you achieve consistent quality and tailored release profiles. HME services support formulation optimization and scale-up.

Benefits of HME Services

Using HME services comes with major advantages. First, you improve solubility of poorly water-soluble drugs. That drives better bioavailability. Second, you achieve uniform content across each dose. This consistency boosts patient safety and regulatory compliance. Third, you enable modified-release profiles without complex coatings. Fourth, you reduce formulation development time and cost. Additionally, you avoid spray-drying or multi-step granulation. Moreover, you create robust formulations that withstand stress. Finally, you get scalable processes that mirror clinical and commercial runs. Overall, proprietary hot melt extrusion and HME services speed market entry and protect IP.

HME Process Workflow

AbbVie’s HME services follow a clear workflow to ensure success. First, feasibility studies test API-polymer compatibility. Scientists run small-scale extrusions to screen formulations. Next, process development teams optimize temperature, screw speed, and torque. They document critical process parameters and material attributes. Then, pilot-scale trials confirm scale-up potential. Pilot runs use mirrored equipment to reflect commercial lines. After that, analytical labs conduct identity, potency, and impurity tests. They use HPLC, DSC, and X-ray diffraction methods. Following successful trials, GMP manufacturing begins in cleanroom suites. Teams maintain real-time monitoring and data logging. Finally, technology transfer teams hand off processes seamlessly. This workflow ensures robust, compliant, and reproducible results.

AbbVie’s Facilities and Capabilities

AbbVie Contract Manufacturing houses advanced HME facilities in the U.S. and Europe. Each site features proprietary twin-screw extruders with precise temperature control. Additionally, they offer modular cleanrooms rated ISO 7 and ISO 8. These spaces support GMP manufacturing and minimize contamination risk. AbbVie’s labs include analytical suites with HPLC, UV, and rheology testing. Moreover, they maintain dedicated pilot plants for process verification. Their teams have expertise in both small molecules and biologics. Furthermore, they handle HPAPI formulations using barrier isolators. AbbVie provides tech-transfer packages to simplify scale-up at partner sites. Overall, their global infrastructure delivers reliable HME services at any scale.

Quality and Compliance in HME

Quality drives every HME project at AbbVie. They follow FDA, EMA, and PMDA guidelines without fail. Their processes adhere to ICH Q8 and Q10 best practices. Cleanrooms undergo routine environmental monitoring and air quality checks. In addition, validated cleaning protocols prevent cross-contamination. Quality teams run in-process checks to catch deviations early. Moreover, they conduct stability studies under ICH conditions. This data supports regulatory filings and ensures product safety. Furthermore, AbbVie holds regular internal audits and external inspections. They use real-time data logging to document process performance. As a result, you get fully compliant and robust HME outputs.

Use Cases and Applications

HME services apply to many dosage forms. For example, you can make immediate-release tablets. You can also produce sustained-release pellets for once-daily dosing. Moreover, you can design taste-masked oral films. In addition, HME supports combination products like fixed-dose blends. It also works for nutraceuticals and veterinary medicines. Furthermore, HME can create amorphous solid dispersions for poorly soluble drugs. Similarly, you can deliver inhalation powders with uniform particle size. This flexibility lets you address diverse market needs. Ultimately, proprietary hot melt extrusion drives innovation across pharma.

Case Study: HME in Action

AbbVie applied proprietary hot melt extrusion to a poorly soluble oncology API. Initial tests showed low dissolution. HME services transformed the API into an amorphous dispersion. As a result, dissolution increased tenfold. Next, the process scaled from grams to 500 kilograms. Teams optimized temperature profiles to maintain stability. They ran GMP batches that met all QC criteria. The final product achieved consistent tablet hardness and release. Regulatory filings included robust stability data under ICH conditions. Consequently, the client advanced to Phase III trials ahead of schedule. This case highlights how HME services accelerate development and deliver clinical success.

Why Partner with AbbVie for HME?

Choosing the right partner makes all the difference. AbbVie offers end-to-end HME services. Their teams guide you from R&D to commercial scale. They maintain tight timelines and clear communication. As a result, you meet critical launch dates with confidence. Moreover, AbbVie integrates seamlessly with your internal processes. In addition, they offer flexible engagement models to fit budgets. Their global footprint provides backup capacity and risk mitigation. Furthermore, you get access to cross-functional experts in chemistry, engineering, and quality. Ultimately, partnering with AbbVie minimizes risk and maximizes success in HME.

Next Steps

Ready to unlock the power of proprietary hot melt extrusion? Contact AbbVie Contract Manufacturing today.
👉 Explore Hot Melt Extrusion Services
Accelerate your formulation success with proven HME expertise.